Employees: 17,700
Size BrightView (BV) is a United States Industrials company (Miscellaneous Commercial Services) with a market value of $803M, the 2364th largest of 3,085 United States companies the cockpit tracks. Shares closed at $8.81 on 18 Nov 2026.
Performance Over six months the shares fell 28.9%, against -3.0% for the median peer and -2.2% for the United States market (cap-weighted) — 4th lowest of 21 in its peer set.
Growth Revenue grew 1.5% over the last twelve months (peer median +5.2%); the operating margin is 3.5% (peer median 9.7%).
Valuation It trades at 19.6× forward earnings against a peer median of 17.7× (7th most expensive of 16).
Capital Return on invested capital runs 5.1 points below its cost of capital (7.8% WACC).
Backlog Backlog (remaining performance obligations) was $430M at 30 Sep 2026, down 7% on a year earlier — 0.2 years of trailing revenue. Backlog detail →
Short interest Short interest is 4.5% of the free float (30 Oct 2026).
Next results Next results expected around 4 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Revenue | $2.71B | $2.71B | $2.67B | $2.77B | $2.82B |
| Revenue growth | — | +1% | -3% | -2% | — |
| Gross profit | $532M | $529M | $593M | $610M | $634M |
| EBITDA | $304M | $308M | $332M | $302M | $275M |
| Net income | $1.00M | $1.00M | $56.0M | $66.4M | -$7.70M |
| Free cash flow | -$40.3M | -$40.3M | $37.6M | $125M | $58.6M |
| Capital expenditure | $225M | $225M | $254M | $78.4M | $71.3M |
| Total debt | $1.09B | $1.09B | $950M | $958M | $1.02B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | BV | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -16.2% | -4.2% | 4th lowest of 21 |
| 6-month return | -28.9% | -3.0% | 4th lowest of 21 |
| Distance from 52-week high | -41.3% | -27.9% | 7th lowest of 21 |
| Revenue growth (TTM) | +1.5% | +5.2% | 8th lowest of 21 |
| Operating margin | 3.5% | 9.7% | 6th lowest of 21 |
| Forward P/E | 19.6× | 17.7× | 7th most expensive of 16 |
| ROIC minus cost of capital | -5.1 pp | +3.1 pp | 7th lowest of 19 |
| EV / EBITDA | 7.9× | 10.6× | 3rd cheapest of 10 |
| Net debt / EBITDA | 3.6× | -0.8× | most indebted of 11 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| BrightView BV | United States | $803M | -29% | +1% | 4% | 19.6× | n/a | n/a |
| Beijing Haitian Ruisheng Science Technology 688787.SS | China | $801M | -37% | +34% | 4% | 126.5× | n/a | n/a |
| Mentari Therapeutics MTRI | United States | $807M | -91% | -83% | -1,239% | n/a | n/a | n/a |
| transcosmos 9715.T | Japan | $814M | -11% | +6% | 4% | 10.1× | -18.2% | +3.2% |
| Karnov KAR.ST | Sweden | $820M | +9% | -4% | 20% | 20.6× | 5.1% | +27.9% |
| TaskUs TASK | United States | $827M | +50% | +9% | 12% | 6.5× | 1.3% | +19.9% |
| Anbang Save-Guard 603373.SS | China | $779M | +6% | -1% | 14% | 38.9× | 5.6% | +5.6% |
| Aimed Bio 0009K0.KS | South Korea | $778M | -61% | +228% | 34% | n/a | 10.2% | +652.2% |
| Beyondsoft 002649.SZ | China | $769M | -14% | -6% | 2% | 24.1× | 7.0% | +9.2% |
| Daqian Ecology & Environment 603955.SS | China | $769M | +21% | +217% | -53% | n/a | n/a | n/a |
| Shaanxi Fenghuo Electronics 000561.SZ | China | $851M | -27% | +8% | -26% | n/a | n/a | n/a |
| Omat Advanced Materials (Guangdong) 688530.SS | China | $757M | -19% | +82% | 9% | n/a | n/a | n/a |
| IP Group plc IPO.L | United Kingdom | $865M | +11% | -37% | 51% | 12.0× | n/a | n/a |
| Xi'an High Voltage Apparatus Research Institute 688334.SS | China | $866M | -11% | +4% | 29% | 20.7× | -2.9% | +20.3% |
| IBEX IBEX | United States | $744M | +79% | +15% | 9% | 13.5× | 1.0% | +7.7% |
| AXISCADES Technologies AXISCADES.NS | India | $871M | -6% | +5% | 10% | 17.7× | n/a | n/a |
| Funshine Culture 300860.SZ | China | $739M | 0% | -49% | -35% | 24.2× | 21.5% | -24.6% |
| NOMURA 9716.T | Japan | $880M | +7% | -10% | 7% | 14.6× | -7.5% | +8.6% |
| Shandong Link Science and Technology 001207.SZ | China | $733M | -24% | +7% | 13% | 11.6× | -5.5% | +18.9% |
| Cuscal CCL.AX | Australia | $728M | +17% | +19% | 12% | 18.1× | n/a | n/a |
| Funai Soken 9757.T | Japan | $724M | +10% | +5% | 25% | 16.2× | -8.7% | +5.9% |
BrightView reported $430M of remaining performance obligations at 30 Sep 2026, down 7% from a year earlier and down 4% from the previous quarter. That is 0.2 years of trailing revenue already under contract. Book-to-bill last quarter: 0.98.